# Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery

> **NCT00845364** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital Birmingham** · enrollment: 290 (actual)

## Conditions studied

- Myocardial Reperfusion Injury
- Cardiac Output, Low

## Interventions

- **DRUG:** Perhexiline
- **DRUG:** Placebo marked PEXSIG

## Key facts

- **NCT ID:** NCT00845364
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2010-05-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845364, "Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00845364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*